Mind Medicine Inc

Company Profile

Mind Medicine Inc had its IPO on 2020-03-03 under the ticker symbol MNMD.

The company operates in the Healthcare sector and Biotechnology industry. Mind Medicine Inc has a staff strength of 48 employees.

Stock update

Shares of Mind Medicine Inc opened at $4.34 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.19 - $4.51, and closed at $4.22.

This is a -2.09% slip from the previous day's closing price.

A total volume of 581,454 shares were traded at the close of the day’s session.

In the last one week, shares of Mind Medicine Inc have increased by +2.68%.

Mind Medicine Inc's Key Ratios

Mind Medicine Inc has a market cap of $163.24 million, indicating a price to book ratio of 0.658 and a price to sales ratio of 0.

In the last 12-months Mind Medicine Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-80931000. The EBITDA ratio measures Mind Medicine Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Mind Medicine Inc’s operating margin was 0% while its return on assets stood at -36.6% with a return of equity of -65.37%.

In Q2, Mind Medicine Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Mind Medicine Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mind Medicine Inc’s profitability.

Mind Medicine Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.8062. Its price to sales ratio in the trailing 12-months stood at 0.

Mind Medicine Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$142.09 million

Total Liabilities

$35.12 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Mind Medicine Inc ended 2024 with $142.09 million in total assets and $0 in total liabilities. Its intangible assets were valued at $142.09 million while shareholder equity stood at $105.97 million.

Mind Medicine Inc ended 2024 with $0 in deferred long-term liabilities, $35.12 million in other current liabilities, in common stock, $-248413000.00 in retained earnings and $19.92 million in goodwill. Its cash balance stood at $116.90 million and cash and short-term investments were $116.90 million. The company’s total short-term debt was $75,000 while long-term debt stood at $0.

Mind Medicine Inc’s total current assets stands at $119.79 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $8.58 million and inventory worth $0.

In 2024, Mind Medicine Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Mind Medicine Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$4.22

52-Week High

$8.16

52-Week Low

$2.12

Analyst Target Price

$8

Mind Medicine Inc stock is currently trading at $4.22 per share. It touched a 52-week high of $8.16 and a 52-week low of $8.16. Analysts tracking the stock have a 12-month average target price of $8.

Its 50-day moving average was $4.2 and 200-day moving average was $3.49 The short ratio stood at 4.76 indicating a short percent outstanding of 0%.

Around 473.8% of the company’s stock are held by insiders while 1186% are held by institutions.